The adrenocorticotropin response to interleukin-1β instilled into the rat median eminence depends on the local release of catecholamines

Shannon G. Matta, Jasbir Singh, Robert Newton, Burt Sharp

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Interleukin-1β (IL-1β) is a potent ACTH secretagogue which activates the release of hypothalamic CRF but is unable to cross the blood brain barrier. Recently, it was reported that IL-1β, instilled directly into the hypothalamic median eminence (ME), rapidly induced ACTH secretion. Thus, due to the lack of a blood brain barrier the ME appears to be a site whereby iv IL-1β can access the brain to stimulate CRF and, consequently, ACTH secretion. To evaluate the role of central catecholamines in this process, 250 g male rats were lesioned with 6-hydroxy-dopamine instilled into the lateral ventricle. Ten days later, rats received recombinant h-IL-1β (10 or 30 ng) into the ME and blood was sampled via indwelling jugular cannulae. The ACTH response to IL-1β, 30 ng, was reduced by approximately 50% in the lesioned rats (P = 0.05), and it was abolished in those receiving IL-1β, 10 ng (P < 0.05). Moreover, in rats given iv IL-1β (1 µg), 6-hydroxy-dopamine significantly reduced the ACTH response by more than 50% (P < 0.001). To determine the effect of acute epinephrine depletion, 2, 3 dichloro-a-methylbenzylamine (DCMB, 60 mg/kg BW) and SKF64139 (SKF) (100 mg/kg BW), inhibitors of the enzyme which converts norepinephrine to epinephrine, were administered ip 4 h before intra-ME IL-1β (30 ng). DCMB reduced the ACTH response by 80% and SKF reduced it to its own baseline. LY 10853, which acutely depletes both norepinephrine and epinephrine, also reduced the ACTH response by 80%. Because of the reported capacities of DCMB and SKF to block α2adrenoreceptors in vitro, yohimbine, an α2receptor antagonist, was studied. Intra- ME yohimbine failed to inhibit the ACTH response to intra- ME IL-10. In contrast, a significant (P < 0.01) dose-dependent, reduction in the ACTH response to intra-ME IL-1β (30 ng) was observed in rats pretreated with either a nonselective a or β adrenoreceptor antagonist (phentolamine, 2-40 ng or propranolol, 2-20 ng, respectively, into the ME). In contrast, intra-ME phentolamine, 20 ng, failed to reduce the ACTH response to iv CRF, 1 Mg/kg BW. Thus, the secretion of ACTH stimulated by the action of IL-1β at the ME depends, in part, on the local secretion of norepinephrine and epinephrine interacting with both a and β adrenergic receptors.

Original languageEnglish (US)
Pages (from-to)2175-2182
Number of pages8
JournalEndocrinology
Volume127
Issue number5
DOIs
StatePublished - Jan 1 1990

Fingerprint

Median Eminence
Interleukin-1
Adrenocorticotropic Hormone
Catecholamines
Epinephrine
Interleukin-10
Norepinephrine
Yohimbine
Phentolamine
Blood-Brain Barrier
Dopamine
Lateral Ventricles
Corticotropin-Releasing Hormone
Enzyme Inhibitors
Propranolol
Adrenergic Receptors
Neck

All Science Journal Classification (ASJC) codes

  • Endocrinology

Cite this

The adrenocorticotropin response to interleukin-1β instilled into the rat median eminence depends on the local release of catecholamines. / Matta, Shannon G.; Singh, Jasbir; Newton, Robert; Sharp, Burt.

In: Endocrinology, Vol. 127, No. 5, 01.01.1990, p. 2175-2182.

Research output: Contribution to journalArticle

@article{787c788ad0b44f16bc682994f206aa83,
title = "The adrenocorticotropin response to interleukin-1β instilled into the rat median eminence depends on the local release of catecholamines",
abstract = "Interleukin-1β (IL-1β) is a potent ACTH secretagogue which activates the release of hypothalamic CRF but is unable to cross the blood brain barrier. Recently, it was reported that IL-1β, instilled directly into the hypothalamic median eminence (ME), rapidly induced ACTH secretion. Thus, due to the lack of a blood brain barrier the ME appears to be a site whereby iv IL-1β can access the brain to stimulate CRF and, consequently, ACTH secretion. To evaluate the role of central catecholamines in this process, 250 g male rats were lesioned with 6-hydroxy-dopamine instilled into the lateral ventricle. Ten days later, rats received recombinant h-IL-1β (10 or 30 ng) into the ME and blood was sampled via indwelling jugular cannulae. The ACTH response to IL-1β, 30 ng, was reduced by approximately 50{\%} in the lesioned rats (P = 0.05), and it was abolished in those receiving IL-1β, 10 ng (P < 0.05). Moreover, in rats given iv IL-1β (1 µg), 6-hydroxy-dopamine significantly reduced the ACTH response by more than 50{\%} (P < 0.001). To determine the effect of acute epinephrine depletion, 2, 3 dichloro-a-methylbenzylamine (DCMB, 60 mg/kg BW) and SKF64139 (SKF) (100 mg/kg BW), inhibitors of the enzyme which converts norepinephrine to epinephrine, were administered ip 4 h before intra-ME IL-1β (30 ng). DCMB reduced the ACTH response by 80{\%} and SKF reduced it to its own baseline. LY 10853, which acutely depletes both norepinephrine and epinephrine, also reduced the ACTH response by 80{\%}. Because of the reported capacities of DCMB and SKF to block α2adrenoreceptors in vitro, yohimbine, an α2receptor antagonist, was studied. Intra- ME yohimbine failed to inhibit the ACTH response to intra- ME IL-10. In contrast, a significant (P < 0.01) dose-dependent, reduction in the ACTH response to intra-ME IL-1β (30 ng) was observed in rats pretreated with either a nonselective a or β adrenoreceptor antagonist (phentolamine, 2-40 ng or propranolol, 2-20 ng, respectively, into the ME). In contrast, intra-ME phentolamine, 20 ng, failed to reduce the ACTH response to iv CRF, 1 Mg/kg BW. Thus, the secretion of ACTH stimulated by the action of IL-1β at the ME depends, in part, on the local secretion of norepinephrine and epinephrine interacting with both a and β adrenergic receptors.",
author = "Matta, {Shannon G.} and Jasbir Singh and Robert Newton and Burt Sharp",
year = "1990",
month = "1",
day = "1",
doi = "10.1210/endo-127-5-2175",
language = "English (US)",
volume = "127",
pages = "2175--2182",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - The adrenocorticotropin response to interleukin-1β instilled into the rat median eminence depends on the local release of catecholamines

AU - Matta, Shannon G.

AU - Singh, Jasbir

AU - Newton, Robert

AU - Sharp, Burt

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Interleukin-1β (IL-1β) is a potent ACTH secretagogue which activates the release of hypothalamic CRF but is unable to cross the blood brain barrier. Recently, it was reported that IL-1β, instilled directly into the hypothalamic median eminence (ME), rapidly induced ACTH secretion. Thus, due to the lack of a blood brain barrier the ME appears to be a site whereby iv IL-1β can access the brain to stimulate CRF and, consequently, ACTH secretion. To evaluate the role of central catecholamines in this process, 250 g male rats were lesioned with 6-hydroxy-dopamine instilled into the lateral ventricle. Ten days later, rats received recombinant h-IL-1β (10 or 30 ng) into the ME and blood was sampled via indwelling jugular cannulae. The ACTH response to IL-1β, 30 ng, was reduced by approximately 50% in the lesioned rats (P = 0.05), and it was abolished in those receiving IL-1β, 10 ng (P < 0.05). Moreover, in rats given iv IL-1β (1 µg), 6-hydroxy-dopamine significantly reduced the ACTH response by more than 50% (P < 0.001). To determine the effect of acute epinephrine depletion, 2, 3 dichloro-a-methylbenzylamine (DCMB, 60 mg/kg BW) and SKF64139 (SKF) (100 mg/kg BW), inhibitors of the enzyme which converts norepinephrine to epinephrine, were administered ip 4 h before intra-ME IL-1β (30 ng). DCMB reduced the ACTH response by 80% and SKF reduced it to its own baseline. LY 10853, which acutely depletes both norepinephrine and epinephrine, also reduced the ACTH response by 80%. Because of the reported capacities of DCMB and SKF to block α2adrenoreceptors in vitro, yohimbine, an α2receptor antagonist, was studied. Intra- ME yohimbine failed to inhibit the ACTH response to intra- ME IL-10. In contrast, a significant (P < 0.01) dose-dependent, reduction in the ACTH response to intra-ME IL-1β (30 ng) was observed in rats pretreated with either a nonselective a or β adrenoreceptor antagonist (phentolamine, 2-40 ng or propranolol, 2-20 ng, respectively, into the ME). In contrast, intra-ME phentolamine, 20 ng, failed to reduce the ACTH response to iv CRF, 1 Mg/kg BW. Thus, the secretion of ACTH stimulated by the action of IL-1β at the ME depends, in part, on the local secretion of norepinephrine and epinephrine interacting with both a and β adrenergic receptors.

AB - Interleukin-1β (IL-1β) is a potent ACTH secretagogue which activates the release of hypothalamic CRF but is unable to cross the blood brain barrier. Recently, it was reported that IL-1β, instilled directly into the hypothalamic median eminence (ME), rapidly induced ACTH secretion. Thus, due to the lack of a blood brain barrier the ME appears to be a site whereby iv IL-1β can access the brain to stimulate CRF and, consequently, ACTH secretion. To evaluate the role of central catecholamines in this process, 250 g male rats were lesioned with 6-hydroxy-dopamine instilled into the lateral ventricle. Ten days later, rats received recombinant h-IL-1β (10 or 30 ng) into the ME and blood was sampled via indwelling jugular cannulae. The ACTH response to IL-1β, 30 ng, was reduced by approximately 50% in the lesioned rats (P = 0.05), and it was abolished in those receiving IL-1β, 10 ng (P < 0.05). Moreover, in rats given iv IL-1β (1 µg), 6-hydroxy-dopamine significantly reduced the ACTH response by more than 50% (P < 0.001). To determine the effect of acute epinephrine depletion, 2, 3 dichloro-a-methylbenzylamine (DCMB, 60 mg/kg BW) and SKF64139 (SKF) (100 mg/kg BW), inhibitors of the enzyme which converts norepinephrine to epinephrine, were administered ip 4 h before intra-ME IL-1β (30 ng). DCMB reduced the ACTH response by 80% and SKF reduced it to its own baseline. LY 10853, which acutely depletes both norepinephrine and epinephrine, also reduced the ACTH response by 80%. Because of the reported capacities of DCMB and SKF to block α2adrenoreceptors in vitro, yohimbine, an α2receptor antagonist, was studied. Intra- ME yohimbine failed to inhibit the ACTH response to intra- ME IL-10. In contrast, a significant (P < 0.01) dose-dependent, reduction in the ACTH response to intra-ME IL-1β (30 ng) was observed in rats pretreated with either a nonselective a or β adrenoreceptor antagonist (phentolamine, 2-40 ng or propranolol, 2-20 ng, respectively, into the ME). In contrast, intra-ME phentolamine, 20 ng, failed to reduce the ACTH response to iv CRF, 1 Mg/kg BW. Thus, the secretion of ACTH stimulated by the action of IL-1β at the ME depends, in part, on the local secretion of norepinephrine and epinephrine interacting with both a and β adrenergic receptors.

UR - http://www.scopus.com/inward/record.url?scp=0025016030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025016030&partnerID=8YFLogxK

U2 - 10.1210/endo-127-5-2175

DO - 10.1210/endo-127-5-2175

M3 - Article

VL - 127

SP - 2175

EP - 2182

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 5

ER -